Plus if you read this article it is the most disgusting article I have ever read - the profitting from cadavers? It seems these movie stars, like Cher and Julia Roberts and maybe even Deinise Rich - who hae their lips puffed out until they can slip kisses Ubangi style under a door (as bob hope once said)....the use material from DEAD BODIES = cadavers = for this "beautification".... Supposedly one not to profit from sale of baby body parts or dead bodies in general....but to fix the worn out lips of Julia Roberts or a Cher - costs minimum of $1,200? These people are ghouls; but more important millions of children were given toxic waste into their bodies; so what is causing diseased cattle if it is not ignorance, is it sabotage? Cui bono - as my old MI6 friend used to say - "always ask yourself, Cui Bono, cui bono". You may pull up entire contents under subject matter....has more data on blood transfusions...but is there a deadly vaccine out there - unclean vaccinaition equipment spreading disease in cattle? Cattle have been living in dung areas for thousands of years....now your children eat meat contaminated with what....E Coli is just a polite word for defacate? Saba Mad Cow Home ... Best Links Two million children innoculated with BSE vaccines Baroness tested for CJD CDJ tonsil study fails to answer key question Backgrounder: what motivated tonsil and appendix study? BSE 'to die out in seven years' (or go on via cow patties) EU adopts tougher controls against mad cow disease French officials report two new cases of mad cow disease Saskatchewan CWD elk death sparks herd quarantine 10 Australian surgery patients exposed to CJD instruments New disease passed by blood transfusions Dead bodies harvested for parts and tissues American, 39, dies of dura mater implant Two million children innoculated with BSE vaccines Daily Express May 2, 200 [minor edits by webmaster] Seven vaccines potentially at risk from BSE and given to millions of children can be identified for the first time by the Daily Express. But alarmingly there is no record of which children received the jabs, produced between 1988 and 1989, at the start of Britain's "mad cow" crisis. The vaccines, using UK-sourced cattle material, were made by two companies, Wellcome and Smithkline, despite warnings that they could pose a risk. The seven vaccines are: 1. Smithkline's MMR (Measles, Mumps, Rubella), finally replaced "by end of 1992 approximately"; 2. Wellcome's combined Diphtheria and Tetanus, last issued by the company in June 1991, with a June 1993 expiry date; 3. Wellcome's DTP (Diphtheria, Tetanus, Pertussis) last issued again in June 1991, with a November 1993 expiry date; 4. Wellcome's single component Diphtheria vaccine, last issued in October 1991, with a November 1993 expiry date; 5. Wellcome's Tetanus, last issued in December 1991, with a December 1993 expiry date. 6.[Wellcome's oral polio vaccine, last issue and expiry dates are "not known". 7. Smithkline's inactivated polio vaccine, apparently used only in foreigners.] Last night Liberal Democrat MP Norman Baker, who has led a crusade on the issue, accused the Department of Health of being "potentially criminally negligent" for allowing the BSE-risk vaccines to be administered to at least two million children for the five years to 1993. But a Department of Health spokeswoman said that if routine vaccinations had been stopped there would have been a "real risk" of serious and potentially fatal infectious diseases among children. She said all of today's vaccines are produced from non-UK bovine material, and insisted the old UK-based vaccines "appear to have no role to date" in the development of the human version of mad cow disease, new variant Creutzfeldt-Jakob Disease (nvCJD). So far 53 people have been killed by the disease, another dozen are dying and the victims include three children, aged 13 to 15. [Today's DoH report shows 68 nvCJD victims as of 28 April 00. ] Public Health Minister Yvette Cooper has told the Commons that some drug companies responded to 1988 reports of BSE by quickly switching to non-UK sources for bovine material for their vaccines. But after a Code of Open Government request for facts, the Daily Express has been told Wellcome continued using UK bovine material in the manufacturing process for four children's vaccines until 1989. Smithidine has said it continued to use UK-sourced material for its Measles, Mumps, Rubella (MMR) vaccine through to February 1990. [These were peak years of the BSE epidemic. A key issue is how long stocks at hand continued to be used. This was apparently until they were all sold or the expiration date reached by 1993. There was apparently never a recall.-- webmaster] Drugs makers were asked to stop doing that in March 1989, but in an obscure sentence the Health Department suggests it "would have taken months" to eradicate UK-sourced material from the manufacturing process entirely. Wellcome's oral polio doses were also manufactured from UK-sourced bovine material through to 1989, although the last issue and expiry dates are "not known". The Medicines Control Agency told the Department of Health that Smithkline's inactivated polio vaccine was also manufactured from UK-sourced bovine material. However, it was said no such vaccine was sold by the firm in the UK. Smithkline Beecham said: 'As of February 1990, Smithkline Beecham Biologicals, our vaccine business, ceased sourcing bovine material of UK origin, and replaced it with material from BSE-free countries. Any stock that was remaining, at the request of the UK authorities, continued to be available for sale." That means unknown quantities of all six routine child immunisations, including Wellcome's oral polio, were kept in doctors' surgeries and were dispensed right through to expiry, towards the end of 1993. But the Health Department admits: "We are unable to provide exact dates on which vaccines manufactured before March 1989 were no longer used. At the time in question, vaccines were not purchased centrally, as they are now." The Liberal Democrats' Mr Baker said: "The Department of Health was potentially criminally negligent in not requiring the immediate withdrawal or cessation of use of vaccines from potentially contaminated sources. "It is also beyond belief the Department should not even have monitored those who were injected, and is now trying to sweep the whole thing under the carpet" Opinion (webmaster): This is good step forward to name the compaines and specific vaccines though it is a pity that England doesn't keep records of who received what vaccine the way normal countries do. The previous two mass outbreaks of TSE attributed to vaccines involved louping ill in the 1930's and a 1999 vaccine in Italy, both produced in sheep or goat brain. An Indian physician has also expressed concern about a widely used human rabies vaccines produced in scrapies-endemic sheep brain in India; CJD surveillance there is minimal. No details are provided above on what part of the bovine is used in producing the vaccines, apparently fetal calf serum or bovine serum albumen are used in human cell culture to grow the viruses. The vaccines had been previously discussed in a Phillips Inquiry memo: bovine blood serum, ox heart infusion, casein (milk protein), fetal calf serum, beef muscle infusion, veal, and unspecified sheep use. Extract from Phillips enquiry, draft factual account 17, 8 Oct 99 14 February 1989 Dr Adams minuting Dr Harris Vaccines: We have contacted all the major vaccine product licence holders whose products are likely to be used in children. Many manufacturers use bovine material. As can be seen, this information is diverse and incomplete. Each company stressed that they could not give an accurate assessment without detailed researches, given the complexity of sourcing/purchasing arrangements. All the licences are detailed in appendix 1 [unavailable]; the overview is as follows: 1. D have polio, measles, mumps, rubella, rotavirus vaccines. All use bovine serum from a UK source and bovine commercial product from unknown source. Some agent comes from the USA and New Zealand. 2. I gave most information (see Appendix 2 [unavailable]). All their vaccines apart from yellow fever, cholera and typhoid contain bovine material: Oral polio; up to 1988, foetal calf serum was used from UK and New Zealand (pooled); since 1988 foetal calf serum only from New Zealand. Large stocks are held. Rubella; bulk was made before 1979 from foetal calf serum from UK and New Zealand. None has been made as there are some 15 years stock. Diphtheria; UK bovine beef muscle and ox heart is used but since the end of 1988 this has been sourced from Eire. There are 1,250 litres of stock. Tetanus; this involves bovine material from UK mainly Scottish. There are 21,000 litres of stock. Pertussis; uses bovine material from the UK. There are 63,000 litres of stock. They consider that to switch to a non-UK source will take a minimum of 6-18 months and to switch to a non-bovine source will take a minimum of five years. 3. E have measles, mumps, MMR, rubella vaccines. These are sourced from the USA and the company believes that US material only is used. 4. J have a measles vaccine using bovine serum from the UK. There are 440,000 units of stock. They have also got MMR using bovine serum from the UK. 5. K have influenza, rubella, measles, MMR vaccines likely to be used in children. Of those they think that only MMR contains bovine material which is probably a French origin. 6. L have diphtheria/tetanus and pertussis on clinical trial [redacted]; These use veal material, some of which has come from the UK and has been made by I (see above). 7. M have influenza vaccines which are made up in egg medium. 8. The Secretary of State has a number of licences. We understand that the inactivated polio vaccine is no longer being used. There is a stock of smallpox vaccine. We have not been able to determine the source material. (Made in sheep very unlikely to certain bovine ingredients). 9. N have acellular triple vaccine in which I material of UK bovine source has been used. As far as I can see Company I is the sole supplier of pertussis vaccine which uses bovine casein digest. You should also be aware that DH has made arrangements for meningococal vaccine to be available, on a named patient basis, from D and K. Both companies use bovine media in production." The Parliamentary Under-Secretary of State, Department of Health (Lord Hunt of Kings Heath): No vaccines or other injectable medicines in use in the United Kingdom contain bovine serum derivatives as ingredients in the finished products. Comment (Kelly): "It seems clear that no bovine derivatives are used in FINISHED products, however they are often used in the culture process. Does this also present a possible risk? Below is the packaging insert for one routine vaccine (inactivated injectable polio vaccine)made by Pasteur Merieux Sérums & Vaccins S. A. Lyon, France (now called Aventis):" IPOLÒ, Poliovirus Vaccine Inactivated, produced by Pasteur Mérieux Sérums Vaccins S.A., is a sterile suspension of three types of poliovirus: Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). IPOLÒ is a highly purified, inactivated poliovirus vaccine produced by microcarrier culture. This culture technique and improvements in purification, concentration and standardization of poliovirus antigen produce a more potent and consistent immunogenic vaccine than the IPV available in the US prior to 1988. The viruses are grown in cultures of V.R. cells, a continuous line of monkey kidney cells, by the microcarrier technique. The cells are grown in Eagle MEM modified medium, supplemented with newborn calf serum tested for adventitious agents prior to use, originated from countries free of bovine spongiform encephalopathy. For viral growth the culture medium is replaced by M-199, without calf serum. ... Neomycin, streptomycin and polymyxin B are used in vaccine production, and although purification procedures eliminate measurable amounts, less than 5 ng neomycin, 200 ng streptomycin and 25 ng polymyxin B per dose may still be present. The residual calf serum protein is less than 1 ppm in the final vaccine. The vaccine is clear and colorless and should be administered intramuscularly or subcutaneously. The documents below were provided by Terry S. Singeltary Sr on 8 May 2000. They are optically character read (scanned into computer) and so may contain typos and unreadable parts. TIP740203/l 0424 CONFIDENTIAL Mr Cunningham CMP3 From: D O Hagger MBI Dr Salisbury MED/IMCD3 Mr Burton PD/STB/PG1B B/17/2 Date: 15.02.1989 Mr Dudley PD/AD4 BOVINE SPONGIFORM ENCEPHALOPATHY 1. The purpose of this minute is to alert you to recent developments on BSE as they affect medicines and to invite representatives to a meeting in Market Towers on 22 February 1989. 2. The report of the Working Party on Bovine Spongiform Encephalopathy (BSE) was submitted by the CMO to the Secretary of State for Health and Minister for Agriculturer on 9 February. 3. The summary at the end of the report records, inter alia: 'we have drawn the attention of the Licensing Authority to the potential of transfer of BSE agent in human and veterinary medicinal products. In paragraph 7 of his submission (Annex A), the CMO notes: "I am also putting work urgently in hand to satisfy myself that everything possible has been done to ensure .... that transfer of the BBE agent in human and veterinary medicinal products does not occur." 4. The Veterinary products Committee meets on 16 February and The committee on Safety of Medicines on 23 February when each will be considering a draft of some joint guidelines for manufacturers of medicinal products which use bovine material as an ingredient or an intermediate in the manufacturing process (Annex B)..... 6. Although a wide range of medicines may be implicated - and the present proposal is to write to companies for more information - an "instant" telephone survey of manufacturer of vaccines used for children has already been undertaken in response to a request from Dr Harris. The results are in Dr Adams' minute of 14 February (Annex C) - the proviso in his second paragraph, last sentence should be noted. 89/02.15/11.1 89/02.15/11.2 MF580439/1 0584 SOUTHWOOD REPORT: BSE AND MEDICINAL PRODUCTS 1. I attach a list of questions on BSE and medicines compiled with the aim of providing question and answer briefing to DH and MAFF Ministers upon publication of the Southwood Report. I have suggested names of those who may be able to provide answers. All recipients are invited to consider which if any important areas have been missed. Also attached is copy QA briefing being proposed by MAFF. I understand MAFF have produced General QA briefing on the reports as a whole. .. MF580439/1 0585 Question 1. Which medicines are affected? (person to provide reply) Dr. Jefferys 2. Are the risks greater with some medicines than others? Dr. Jefferys 3. Why are medicines affected? Dr. Jefferys 4. Are some affected products available over the counter from pharmacies or shops? Dr. Purves 5. Are only UK products at risk? Dr. Jefferys 6. Are existing stocks safe? Dr. Jefferys 7. Are pre 1980 stocks available? Mr. Burton 8. Are these alternatives to the use of bovine material? Dr. Purves 9. Why can't we throw away suspect stock and import or manufacture safe medicines? Dr. Jefferys 10. Which patients are at risk? Dr. Jefferys 11. Are some patients particularly vulnerable? Dr Jefferys 12. What risks exist to those who have already used these medicines? Dr. Jefferys 13. HOW might patients be affected? Dr. Jefferys 14. Can BSE be transmitted to patients by medicines? Dr. Jefferys 15. How long will it be before risks are quantified? Dr. Jefferys 100 89/02.17/10.2 MF580439/1 0586 16. What research is going on to find out if medicines can transmit this disease and if any patients have been affected? Dr Jefferys 17. Could recent cases of Creuuzfeld Jacob Disease have been caused by transmission of BSE through medicines? Dr. Jefferys 18. What action is the Licensing Authority taking to ensure proper scrutinising of source materials and manufacturing processes? Dr. Jefferys/Dr. Purves 19. Are the guidelines practical? Dr. Jefferys/Dr. Purves 20. Will the guidelines remove the risk? Dr. Jefferys 21. How will the guidelines be enforced? Dr. Jefferys/Dr. Purves 22. How soon will they come into force? Dr. Jefferys 23. Will the guidelines be published? Mr. Hagger 24. What is being done to reassure patients, parents etc? Mr. Hagger/Dr. Salisbury 25. What advice is being given to doctors, pharmacists etc? Mr. Hagger 26. What advice is the Government giving about its vaccination programme? Dr. Salisbury 27. Is the vaccination programme put at risk because of BSE? Dr. Salisbury 89/02.17/10.3 Q. Will government act on this? A. Yes - thymus is not used in preparation of baby foods but it is contacting all manufacturers to seek their urgent views on use of kidneys and liver from ruminants. Will consider any necessary measures in the light of their response. VETERINARY MEDICINES Q. Can medicines spread BSE to other cattle/animals? A. The report describes any risks as remote. Q. How can risks be avoided? A. In liaison with the DOH the Veterinary Products Committee is examining guidelines for the veterinary pharmaceutical industry which will be issued shortly. Q. What will Guidelines say? A. In essence they call for non-bovine sources to be used if possible, including synthetic material of biotechnological origin. Where this is not possible the industry should look for sources which are free of BSE and which are collected in a manner which avoids risk of contamination by the BSE agent. 89/02.17/10.4 MF580439/1 0588 A. Bovine source material is used in [garbled, cannot read...TSS] and some other medicines. Q. How many medicines are involved? A. Computer records show that about 300 of the 3,050 veterinary medicines licensed in the U.K. are manufactured directly from bovine source material. However, other medicines may be produced from bovine sources and a letter is going to all license holders so that a comprehensive list can be drawn up. 89/06.19/8.1 BSE3/1 0191 Hr J Maslin (MAFF) Ref: Maslin3g From: Dr H Pickles Med SEB/B Date: 3 July 1989 CATTLE BY-PRODUCTS AND BSE I was interested to see the list of by-products sent to the HSE. Those of particular concern included: * small intestines: sutures (I thought the source was ovine but you are checking this) * spinal cord: pharmaceuticals * thymus: pharmaceuticals Are you able to give me more information on which UK manufacturers use these materials? Our proposed ban on bovine offal for human consumption would not affect these uses, I assume. Id No. 1934/RD/1 89/08.10/6.1 117A BOVINE SPONGIFORM ENCEPHALAPATHY MEETING HELD ON 21 AUGUST 1989 AT 2;15 IN ROOM 720 Miss M Duncan (Chairman) Mr W Burton Dr E Hoxey Mrs J Dhell Ms K Turner Dr S Whittle Mr N Weatherhead ... 5. The MCA had sent 2700 questionnaires out, 1,124 had made valid returns; of these 122 use animal material of some kind and there are 582 products involved. ... 6. The MCA/BSE working group will meet on 6th September. Their aim is to review responses from professional officers in MCA who have suggested seven categories of importance (with 1 being the most important} for medical products: ID 2267/NRE/1 89/08.21/10.1 1. Products with Bovine brain/lymph tissue administered by injection. 2. Products with bovine tissue other than brain/lymph administered by inection. 3. Tissue implants/open wound dressing/surgical materials/dental and ophthlamic products with bovine ingredients. 4. Products with bovine ingredients administered topically. 5. Products with bovine ingredients administered orally. 6. Products with other animal/fish/insect/bird ingredients administered by injection/topically/oral routes. 7. Products with ingredients derived from animal material by chemical processing (eg stearic acid, gelatine, lanolin ext. The BSE working group will decide which of these are important, and should be examined more closely, and which categories can be eliminated. The responses by the companies were presented by Ms Turner and were categorised by MCA standards, the products that were discussed were all low volume usage products eg sutures, heart valves. 8. As the responses included some materials of human origin it was decided that more information should be sought about CJD. There had been 2 recent deaths reported associated with human growth hormone. These were being investigated. 9. Re-editing of the Paper on "Incubation of Scrapie-like Agents" It was suggested that the document could be sent out to companies with the non-standard sterilization Document. The document could have severe implications on the companies whose products have a high risk factor as decided by the MCA working group.... 11. The Need for a list of High Priority Implantables The commitee decided that no list is necessary as all implantables, including ones from a human source are of high priority. Concern was shown over Killingbeck who use human material but had not yet responded. The company will be chased for a response. Concern was shown over the fact that there may be other scrapie-like organisms in other animals and further enquiries should be made. 2334q/RD/4 89/08.21/10.7 BOVINE MATERIAL USED IN THE MANUFACTURE OF SURGICAL IMPLANTS AND BLOOD CONTACT MEDICAL DEVICES Glutaraldehyde, formaldehyde, and ethylene oxide are used in the sterilization of these devices. However, glutaraldehyde 4,10,12,19 formaldehyde 5,10,11,13,19 and ethylene oxide 19,23 are all reported to be ineffective methods for sterilization of material infected with the agents of CJD or scrapie. Previous advice and research using the agents of CJD and scrapie, has concentrated on the decontamination of equipment; protection of health care workers from contaminated human material; human growth hormone; and dura mater. The methods developed may not be directly applicable or transferable to material of bovine origin for use in human implantation. 2334q/RD/7 89/08.21/10.10 BSE11/2 020 SC1337 DEPARTMENT OF HEALTH AND SOCIAL SECURITY Richmood House 79 Whitehall, London SW1A 2NS Telephone 01-210-3000 >From the Chief Medical Officer Sir Donald Acheson KBE DM DSc FRCP FFCM FFOM Mr K C Meldrum Chief Veterinary Officer Ministry of Agriculture, Fisheries and Food Government Buildings Hook Rise South Tolworth Surbiton Surrey KT6 7NG 3 January 1990 Dear Mr. Meldrum, BOVINE SPONGIFORM ENCEPHALOPATHY You will recall that we have previously discussed the potential risks of BSE occurring in other Countries as a result of the continuing export from the UK of meat and bone that may be contaminated by scrapie or possibly BSE. I remain concerned that we are not being consistent in our attempts to contain the risks of BSE. Having banned the feeding of meat and bone meal to ruminants in 1988, we should take steps to prevent these UK products being fed to ruminants in other countries. This could be achieved either through a ban on the export of meat and bone meal, or at least by the proper labelling of these products to make it absolutely clear they should not be fed to ruminants. Unless some such action is taken the difficult problems we have faced with BSE may well occur in other countries who import UK meat and bone meal. Surely it is short sighted for us to risk being seen in future as having been responsible for the introduction of BSE to the food chain in other countries. I would be very interested to hear how you feel this gap in the present prcautionary measures to eliminate BSE should be closed. We should be aiming at the global elimination of this new bovine disease. The export of our meat and bone meal is a continuing risk to other countries. Signed Sincerely Donald Acheson Did the US import fetal calf serum and vaccines from BSE-affected countries? 3002.10.0040: FETAL BOVINE SERUM (FBS) U.S. Imports for Consumption: December 1998 and 1998 Year-to-Date (Customs Value, in Thousands of Dollars) (Units of Quantity: Kilograms) Country Quantity Value Quantity Value ============================================================ WORLD TOTAL . . . . 2,727 233 131,486 8,502 Australia . . . . . --- --- 19,637 2,623 Austria . . . . . . --- --- 2,400 191 Belgium . . . . . . --- --- 17 32 Canada . . . . . .. 900 110 30,983 3,220 Costa Rica . . . .. 500 20 4,677 169 Federal Rep. of Germany --- --- 105 21 Finland . . . . . . 1 8 9 83 France . . . . . .. --- --- 73 7 Guatemala . . . . . --- --- 719 42 Honduras . . . . .. --- --- 1,108 88 Israel . . . . . .. --- --- 24 165 Netherlands . . . . --- --- 1 5 New Zealand . . . . 26 5 65,953 913 Panama . . . . . .. --- --- 1,195 64 Switzerland . . . . 971 8 1,078 23 United Kingdom . . . 329 82 743 756 Uruguay . . . . . . --- --- 2,764 98 ------------------------------------------------------------ 3002.20.0000: VACCINES FOR HUMAN MEDICINE U.S. Imports for Consumption: December 1998 and 1998 Year-to-Date (Customs Value, in Thousands of Dollars) (Units of Quantity: Kilograms) Country Quantity Value Quantity Value ============================================================ WORLD TOTAL . . . . 25,702 26,150 550,258 378,735 Austria . . . . . . --- --- 45 225 Belgium . . . . . . 14,311 12,029 248,041 199,036 Canada . . . . . .. 1,109 1,527 15,798 16,305 Denmark . . . . . . 80 234 246 682 Federal Rep. of Germany 1,064 4,073 12,001 6,329 France . . . . . .. 3,902 4,859 87,879 92,845 Ireland . . . . . . --- --- 120 478 Italy . . . . . . . --- --- 2,359 81 Japan . . . . . . . 445 1,903 11,350 11,298 Netherlands . . . . --- --- 94 6 Republic Of South Africa --- --- 2 1 Spain . . . . . . . --- --- 60 30 Switzerland . . . . 716 353 9,303 4,271 United Kingdom . .. 4,075 1,172 162,960 47,148 ------------------------------------------------------------ 3002.30.0000: VACCINES FOR VETRINARY MEDICINE U.S. Imports for Consumption: December 1998 and 1998 Year-to-Date (Customs Value, in Thousands of Dollars) (Units of Quantity: Kilograms) Country Quantity Value Quantity Value ============================================================ WORLD TOTAL . . . . 6,528 237 87,149 2,715 Canada . . . . . .. --- --- 2,637 305 Federal Rep. of Germany --- --- 104 5 Netherlands . . . . 138 64 472 192 New Zealand . . . . 6,390 173 83,882 1,895 United Kingdom . . . --- --- 54 318 Peer tested for CJD Sat, May 6, 2000 By Anjali Kwatra, PA News Comment (webmaster): While rumors swirl about new variant CJD, fueled by the Baroness' association with animals, this case may very well be simply sporadic CJD. The BBC Radio news specifically stated that nvCJD was suspected but no supporting reasons were given out. The oldest known case is 52, a gap of some 14 years. No mention is made of a brain biopsy; pulvinar MRI has not been validated at this age. Vice President of the RSPCA Baroness Ziki Wharton is in hospital undergoing tests for variant CJD - the human form of mad cow disease, it was revealed today. Baroness Wharton, 66, a crossbench peer in the House of Lords, is "seriously unwell" in Charing Cross Hospital in west London. This page is too big to be shown completely.
http://www.mad-cow.org/00/may00_news.html
